RareSearch logo

The Wistar Institute Proteomics Facility

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Brett Marks profile

Brett Marks

🇬🇧 United Kingdom

9.2

    Reviewed:

  • - Regulatory Strategy Consulting
  • - 4 weeks July - August 2024
  • - Biotech Startup

Thorough and strategic regulatory strategy consulting.

The regulatory strategy consulting services were thorough and provided us with a clear pathway to regulatory approval. The team's deep understanding of the regulatory landscape was invaluable, and their strategic advice was spot on.

Kerry Swift profile

Kerry Swift

🇩🇪 Germany

9.3

    Reviewed:

  • - Market Access Strategy
  • - 6 weeks January - February 2024
  • - Pharmaceutical Company

Strategic market access analysis, insightful recommendations.

The market access analysis provided strategic insights that were crucial to our launch strategy. The team's recommendations were data-driven and actionable, helping us to make informed decisions.

Julian Aufderhar profile

Julian Aufderhar

🇮🇹 Italy

8.8

    Reviewed:

  • - Biostatistical Design
  • - 4 weeks May - June 2023
  • - Research Institution

Excellent biostatistical support, clear and actionable insights.

The biostatistical support provided was top-notch, offering clear and actionable insights that were critical to the success of our study. The team was responsive and worked closely with us to ensure the analysis met our specific needs.

Ms. Louise Brakus profile

Ms. Louise Brakus

🇮🇳 India

9

    Reviewed:

  • - Clinical Protocol Design
  • - 6 weeks April - May 2023
  • - Pharmaceutical Company

Comprehensive protocol design, very detailed and precise.

The protocol design provided was comprehensive and very detailed. It laid a strong foundation for our clinical trial, ensuring that all regulatory and ethical considerations were addressed. The attention to detail was impressive.

Tommy Grant profile

Tommy Grant

🇩🇪 Germany

8.8

    Reviewed:

  • - Companion Diagnostics Development
  • - 16 weeks January - May 2024
  • - Pharmaceutical Company

High-quality companion diagnostics development, delivered on time.

The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.